These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Studies of the components of the fibrinolytic system in the amniotic fluid]. Giambanco V; Di Grigoli D Quad Clin Ostet Ginecol; 1968 Oct; 23(10):1193-205. PubMed ID: 4245051 [No Abstract] [Full Text] [Related]
5. STUDIES ON HYALINE MEMBRANE DISEASE. II. THE ONTOGENY OF THE FIBRINOLYSIN SYSTEM. AMBRUS CM; WEINTRAUB DH; NISWANDER KR; AMBRUS JL Pediatrics; 1965 Jan; 35():91-6. PubMed ID: 14223231 [No Abstract] [Full Text] [Related]
6. Studies on the ontogeny and significance in neonatal disease of the fibrinolysin system and of fibrin stabilizing factor. Ambrus CM; Weintraub D; Niswander K; Ambrus JL Thromb Diath Haemorrh; 1968 Jul; 19(3):599-600. PubMed ID: 4236829 [No Abstract] [Full Text] [Related]
7. Ontogeny of fibrinolysin system and its role in pathogenesis of hyaline membrane disease of infants. Ambrus CM Fed Proc; 1966; 25(1):68-72. PubMed ID: 5006574 [No Abstract] [Full Text] [Related]
8. An unsatisfactory method for experimental production of hyaline membrane disease. Aslami A; Race GJ; Finney JW; Urschel HC Tex Rep Biol Med; 1968; 26(2):249-51. PubMed ID: 5187302 [No Abstract] [Full Text] [Related]
9. Clinical significance of antithrombin III, plasminogen and alpha 2-plasmin inhibitor in perinatal period. Fuse Y; Fuse K Asia Oceania J Obstet Gynaecol; 1985 Mar; 11(1):121-5. PubMed ID: 3160323 [No Abstract] [Full Text] [Related]
10. [Experimental studies on contraindication of adrenochrome in hyaline membrane syndrome (respiratory distress syndrome)]. Keuth U; Allardt HJ Z Kinderheilkd; 1971; 111(3):205-16. PubMed ID: 5157651 [No Abstract] [Full Text] [Related]
11. The CO2-induced hyaline membrane disease as a biological model for the study of lung cell injury and repair. Schaefer KE Aspen Emphysema Conf; 1968; 11():321-2. PubMed ID: 5190719 [No Abstract] [Full Text] [Related]
12. EFFECT OF ANTICOAGULANT, FIBRINOLYTIC, AND ANTIFIBRINOLYTIC AGENTS ON EXPERIMENTAL HYALINE MEMBRANES. FUJIKURA T Am J Obstet Gynecol; 1964 Dec; 90():850-3. PubMed ID: 14241506 [No Abstract] [Full Text] [Related]
13. [New theory of fibrinolytic mechanism in the development of hyaline membrane disease in newborn infants]. Uszyńska-Folejewska R; Uszyński M Pediatr Pol; 1975 Dec; 50(12):1513-5. PubMed ID: 127976 [No Abstract] [Full Text] [Related]
14. Changes in the fibrinolysin system in infantile and adult respiratory distress syndrome (ARDS), caused by trauma and/or septic shock in patients and in experimental animals. Ambrus JL; Ambrus CM J Med; 1990; 21(1-2):67-84. PubMed ID: 2145377 [TBL] [Abstract][Full Text] [Related]
16. [Fibrinolytic homeostasis in pregnancy. I. Quantitative relations between pro- and anti-fibrinolytic factors. Clinical and experimental study]. Giordano G Minerva Ginecol; 1969 Jul; 21(14):888-92. PubMed ID: 4249426 [No Abstract] [Full Text] [Related]
17. [Effect of angiotensin II on indices of the fibrinolysis system in experiments in vitro]. Golubenkova NI Lab Delo; 1981; (12):720-2. PubMed ID: 6172641 [No Abstract] [Full Text] [Related]
18. Substrate specificity of plasminogen activator in the lungs of rabbits and rodents. Ionic enhancement of plasminogen activator activity. Lieberman J Lab Invest; 1968 Nov; 19(5):466-72. PubMed ID: 4235267 [No Abstract] [Full Text] [Related]
19. Treatment of hyaline-membrane disease. Shepard FM N Engl J Med; 1969 Feb; 280(6):331. PubMed ID: 5762382 [No Abstract] [Full Text] [Related]